TRNS Insider Filing: Dawn DePerrior RSU Vesting and Option Grant
Rhea-AI Filing Summary
Reporting person: Dawn DePerrior, a director of Transcat, Inc. (TRNS). The Form 4 discloses equity awards and option activity reported for transactions on September 10-11, 2025. On 09/10/2025 Ms. DePerrior was awarded 1,587 restricted stock units (RSUs) that convert one-for-one into common shares and vest on 09/10/2026. On 09/11/2025 704 RSUs vested and converted into 704 shares of common stock, increasing her beneficial ownership by that amount. Also reported is a stock option to purchase 10,000 shares at an exercise price of $92.92 that vests pro rata over five years from the grant date and expires 10/26/2033. All reported holdings are direct.
Positive
- Receipt and conversion of 704 vested RSUs into common stock adds to director's direct ownership
- Grant of 10,000-share stock option with long-dated expiration aligns director incentives with long-term performance
- New RSU award (1,587 units) with one-year vesting provides retention incentive
Negative
- None.
Insights
TL;DR Director received routine equity compensation: time-based RSUs, vested RSUs converted, and a multi-year option grant.
These transactions are consistent with standard director and executive compensation practices. The 1,587 RSU grant (vesting in one year) and the immediate vesting/conversion of 704 RSUs reflect time-based incentive pay rather than opportunistic insider trading. The 10,000-share option at $92.92 with five-year pro rata vesting aligns long-term incentives with shareholder value over multiple years. All holdings are reported as direct, simplifying governance oversight. No sales or dispositions were reported.
TL;DR Materiality is limited: awards are compensation-related and do not indicate an unusual liquidity event.
The vested 704 shares increase the director's stake modestly but are small relative to typical public-company floats; the 10,000-share option represents potential future dilution only if exercised. There is no cash sale, no transfer to an insider vehicle, and no hedging disclosed. From a market-impact perspective these filings are routine and unlikely to change valuation assumptions absent additional context on outstanding share count or total director holdings.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 704 | $0.00 | -- |
| Exercise | Common Stock, $.50 par value | 704 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 1,587 | $0.00 | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Footnotes (1)
- These restricted stock units ("RSUs") convert into common stock on a one-for-one basis. These RSUs were granted in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award agreement, vest on September 10, 2026. These RSUs vested on September 11, 2025. This option vests and becomes exercisable pro rata with respect to one-fifth of the shares subject to the option on the first, second, third, fourth and fifth anniversaries of the date of grant, except as otherwise provided in the award notice.
